Locations:

Interventional Cardiology

July 1, 2022/Heart, Vascular and Thoracic/Interventional Cardiology

Coronary Sinus Reducing Device: A New Option for Refractory Angina May Soon Be at Hand

Pivotal COSIRA-II multicenter U.S. clinical trial is underway

May 9, 2022/Heart, Vascular and Thoracic/Interventional Cardiology

Same-Day Discharge After Transfemoral TAVR Is Feasible and Safe in Appropriate Patients

Protocol promises to shape patient satisfaction, hospital resource utilization

February 28, 2022/Heart, Vascular and Thoracic/Interventional Cardiology

INOCA: A Common, Dangerous, Often Overlooked Cause of Chest Pain

What to do when a patient’s ischemia is not due to coronary artery stenosis

January 12, 2022/Heart, Vascular and Thoracic/Interventional Cardiology

What’s the Best TAVR Approach When Transfemoral Access Isn’t Feasible?

New study details trends in alternative-access TAVR from Cleveland Clinic

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

21-HVI-2541212_STEMI-emergency-care_650x450

December 6, 2021/Heart, Vascular and Thoracic/Interventional Cardiology

Socioeconomic Disparities in STEMI Care: A Promising Blueprint for Leveling the Playing Field

Study shows STEMI protocol closes traditional gaps in care metrics and mortality

October 11, 2021/Heart, Vascular and Thoracic/Interventional Cardiology

Study of STEMI Protocol Shows Sustained Success in Closing the Gender Care Gap

Elimination of most sex-related differences maintained five years after protocol adoption

20-HVI-2013162_STEMI emergency care_650x450

December 21, 2020/Heart, Vascular and Thoracic/Interventional Cardiology

Comprehensive STEMI Protocol Reduces Cardiogenic Shock Incidence and Mortality

Four-point protocol improves outcomes in high-risk patients, earns award for operational excellence

BackPage 3 of 3Next